7 reports of this reaction
1.9% of all SODIUM SULFACETAMIDE reports
#9 most reported adverse reaction
SUICIDAL IDEATION is the #9 most commonly reported adverse reaction for SODIUM SULFACETAMIDE, manufactured by Mission Pharmacal Company. There are 7 FDA adverse event reports linking SODIUM SULFACETAMIDE to SUICIDAL IDEATION. This represents approximately 1.9% of all 367 adverse event reports for this drug.
Patients taking SODIUM SULFACETAMIDE who experience suicidal ideation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SUICIDAL IDEATION is a less commonly reported adverse event for SODIUM SULFACETAMIDE, but still significant enough to appear in the safety profile.
In addition to suicidal ideation, the following adverse reactions have been reported for SODIUM SULFACETAMIDE:
The following drugs have also been linked to suicidal ideation in FDA adverse event reports:
SUICIDAL IDEATION has been reported as an adverse event in 7 FDA reports for SODIUM SULFACETAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SUICIDAL IDEATION accounts for approximately 1.9% of all adverse event reports for SODIUM SULFACETAMIDE, making it a notable side effect.
If you experience suicidal ideation while taking SODIUM SULFACETAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.